Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RROPE: Radium-223 and Radiotherapy in Oligometastatic Prostate Cancer
NCT03304418Phase 2Completed
- Sponsor
- University of Utah
- Start
- Feb 2018
- Primary completion
- Sep 2022
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of radium-223 dichloride in prostate cancer (PCa), sponsored by University of Utah. Started Feb 2018; status: completed.
02
Drugs
radium-223 dichloride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03304418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03304418.